Hone Health and Marek Health both put a prescribing clinician between you and testosterone therapy, and both retest on a schedule. The overlap ends there. Hone Health runs one narrow pathway at a fixed monthly rate: an at-home finger-prick hormone test, a telehealth clinician review, and medication shipped to your door. Marek Health runs a coaching layer over a deep a la carte lab menu with a wider prescription list, and bills each panel and each medication as its own line. The real decision is scope and cost structure.
The Verdict
What each platform actually is
Hone Health
Hone Health sells a hormone-optimization membership for men, delivered entirely by telehealth. The first thing you physically receive is a finger-prick collection kit that ships to your home. You return the sample by mail and results land 5–7 days later. A telehealth clinician reviews those results and determines whether you are a TRT candidate. If you are, medication is prescribed and dispensed through a partner pharmacy, and the membership continues at a monthly rate. Retesting for TRT patients runs quarterly. The base panel is hormone-focused and limited — Hone Health does not sell a broad longevity panel, and metabolic, thyroid, and inflammatory markers are not part of the standard product. TRT is the primary prescription pathway; peptide options are more limited.
Marek Health
Marek Health sells a physician-led optimization service with a coaching layer on top. Two people are involved: a coach who works through your results with you, and a physician who owns the prescribing. What you get is access to an a la carte lab menu — the deepest in the physician-led telehealth category — drawn at a partner lab, which means a venous blood draw rather than a home kit. The prescription list covers TRT, select peptides, and ancillaries such as aromatase inhibitors and HCG where clinically indicated. Retesting runs every 8–12 weeks during active titration. Marek Health does not bundle labs or medication into a flat fee, so the platform does not produce a single quotable annual price.
Side by side on the standard rubric
The same nine criteria used on every platform page. The two columns diverge most on draw type, retest cadence, and how the bill is assembled.
| Criterion | Hone Health | Marek Health |
|---|---|---|
| Annual price (entry) | ~$540–$2,640/yr | $2,500–$6,000+/yr all-in |
| Biomarkers (base panel) | Hormone-focused (limited) | A la carte (deep menu) |
| Physician access | Bundled — telehealth clinician | Bundled — physician-led |
| Prescription pathway | TRT primarily | TRT · peptides · ancillaries |
| Retest cadence | Quarterly for TRT patients | Every 8–12 weeks per protocol |
| Ongoing reassessment | Clinician + TRT dose adjustment | Coaching + physician dose management |
| Draw type | At-home finger-prick kit | Partner lab |
| Hidden costs | TRT medication separate | Every lab and medication is a line item |
| Public litigation | None publicly identified (as of Aug 2026) | None publicly identified (as of Aug 2026) |
| Best for | TRT-only candidates | Advanced biohackers on hormone/peptide protocols |
What each actually costs
| Cost layer | Hone Health | Marek Health |
|---|---|---|
| Entry price | ~$45/month for the at-home hormone test plus membership | ~$200–$400 initial physician consult, then ~$99+/month coaching |
| Typical add-ons | TRT medication, which takes an active protocol to $150–$220+/month | Baseline panel ~$400–$800; follow-up panels ~$200–$500 every 8–12 weeks; medications priced by protocol |
| Realistic year-one all-in | ~$540 if you test and are not prescribed; ~$1,800–$2,640 on an active protocol | $2,500–$6,000+ depending on lab depth and protocol |
| Year two (ongoing) | Roughly unchanged — there is no one-time onboarding fee to drop off | ~$2,300–$5,600+ once the one-time consult falls away; lower again if panel frequency drops |
| What is billed separately | TRT medication | Every lab panel, every prescription, every ancillary |
Hone Health's year-one cost turns on a single decision: whether a clinician prescribes. Test-and-membership alone sits near $45 a month, so a year of testing without treatment lands around $540. Once TRT starts, the full protocol including medication runs $150–$220+ a month, which is $1,800–$2,640 across twelve months. There is no separate onboarding fee to fall away, so year two looks like year one at whichever tier you settled into. The line that actually moves is medication, billed separately from the membership and priced by the ester and dose your clinician selects.
Marek Health's year-one cost is assembled rather than quoted. The initial physician consult runs $200–$400, coaching runs about $99 a month, a comprehensive baseline panel runs $400–$800, and each follow-up panel runs $200–$500 at an 8–12 week cadence — roughly four to six panels in a first year of active titration. Medications sit on top, priced by protocol. That is how the $2,500–$6,000+ range arises. Year two drops by the one-time consult, to roughly $2,300–$5,600+, and drops further if a settled protocol means fewer panels.
Where Hone Health leads
- Collection without a lab visit. The finger-prick kit removes the draw appointment entirely. You collect at home, mail the sample, and results come back in 5–7 days.
- A predictable monthly bill. Membership and testing sit at one rate, and medication is the only variable line, so the annual figure is knowable before you start.
- Lower entry cost. Around $45 a month buys the hormone test and a clinician's read on whether you are a candidate, before any commitment to treatment.
- One continuous flow. Test, review, prescription, and shipped medication all run inside the platform, with no lab order to carry somewhere else.
- Scope match for a single question. The product answers one clinical question, so onboarding never asks you to select panels or choose between protocols.
Where Marek Health leads
- Lab menu depth. The a la carte menu is the deepest in the physician-led telehealth category, so a protocol question can be answered with a specific marker rather than an inference.
- Titration cadence. Panels every 8–12 weeks during active adjustment give the physician roughly four to six data points a year to move a dose against.
- Prescription breadth. Beyond TRT, clinicians can prescribe select peptides and ancillaries including aromatase inhibitors and HCG where clinically indicated.
- Venous draw at a partner lab. A full venous sample supports panels well beyond the hormone markers a mail-in kit is built around.
- A separate coaching layer. A coach reads results with you between physician touchpoints, which is a distinct role from the one that signs the prescription.
Trade-offs to weigh
Hone Health trade-offs
- Panel breadth. The base panel is hormone-focused. Thyroid, metabolic, and inflammatory drivers that often sit underneath fatigue are not part of the standard product.
- Quarterly cadence. Roughly thirteen weeks pass between data points, so a dose set too high or too low stays that way for a full quarter before the next panel confirms it.
- Medication is a separate charge. The membership rate does not include TRT; $150–$220+ a month is what an active protocol actually costs.
- Narrow prescription list. TRT is the primary pathway, so a plan that grows to include peptides or ancillaries reaches the edge of the product.
Marek Health trade-offs
- The price is not quotable up front. A la carte billing means the year-one number depends on panels you have not chosen yet; the stated range spans $2,500 to $6,000+.
- It expects your participation. The platform works best when you can take part in deciding which labs to run, which is a real demand on a first-time patient.
- Draws, not mail-in. Every panel is a venous draw at a partner lab on their schedule — as many as six trips in a year at the faster cadence.
- Still hormone-first in scope. Depth on hormones and peptides does not make it a general longevity program; cardiovascular and metabolic work is less central to the product.
Who should pick each
Pick Hone Health if: you are a man over 35 with symptoms pointing at testosterone — flat energy, low libido, poor recovery — and you want that one question answered without assembling a protocol. You want the monthly number fixed before you begin, you would rather collect a sample at your kitchen table than book a draw, and you have no interest in selecting labs yourself. Budget sits under roughly $2,600 for the year.
Pick Marek Health if: you are already on a hormone protocol or heading into one, you want peptides or ancillaries managed alongside it, and you want a physician moving your dose on eight-to-twelve-week data rather than quarterly. You can absorb a year-one bill anywhere between $2,500 and $6,000, you will show up for venous draws, and you want a coach working through panels with you between physician visits.
Who should pick neither
Both platforms begin from the premise that hormones are the problem. If that has not been established, treating testosterone first can obscure the actual driver. Thyroid dysfunction, iron deficiency, untreated sleep apnea, and depression all produce the flat energy and low libido that send men to a TRT clinic, and a hormone-focused panel is not built to separate them. Establishing a broad baseline before a prescription is usually the cheaper sequence.
- Doctor-led options compared — Fountain Life, Lifeforce, Maximus, and Opt Health each bundle a clinician with a broader panel than either platform here.
- An in-network primary care workup. A physical with a full metabolic panel, thyroid markers, ferritin, and a morning total and free testosterone often costs a copay and rules several causes in or out before you pay any membership.
- A sleep evaluation, if the fatigue comes with snoring or unrefreshing sleep. Untreated sleep apnea is a recognized contributor to both daytime fatigue and suppressed testosterone, and no telehealth hormone panel detects it.
- Maximus vs Hone Health — if you may want children, enclomiphene changes the shortlist before price does.
Can you use both?
Running both at once mostly duplicates. Each includes a prescribing clinician and each retests hormones, so a simultaneous stack pays two memberships to manage the same axis. More importantly, it puts two prescribers on one patient, and a physician adjusting a testosterone dose needs to know the whole dose. If you did overlap them for a full year, the combined bill would run roughly $3,000 to $8,600 — a large share of that buying a second set of hormone panels.
Sequential use is the defensible version. Start on Hone Health to establish candidacy and get a first year of straightforward TRT at a price you can predict. Move to Marek Health if the protocol grows to include peptides or ancillaries, or if a quarterly cadence proves too slow to settle your dose. The one situation where a short overlap makes sense is the handover itself: keeping the first membership active until the new physician has a baseline draw in hand avoids a gap in an active prescription.
What the rubric does not capture
The rubric records that both platforms include a clinician. It does not record who that clinician is or how much of them you get. On Hone Health the contact is a telehealth clinician at defined checkpoints — the results review and the follow-ups — and the interaction is built to be brief because the decision set is small. On Marek Health there are two relationships to maintain: a coach who works through the panel with you and a physician who signs the protocol. More total attention, and more of your time spent inside the platform.
The sharper difference is what happens when a number comes back out of range. At a quarterly cadence, a mistitrated dose on Hone Health is confirmed and corrected at the next scheduled panel, which means it runs for a full quarter first. At an 8–12 week cadence, Marek Health can confirm and move in roughly half that window — but the extra panel costs $200–$500 each time you pull that lever. Speed of correction and cost of correction are the same dial turned in opposite directions, and no rubric row shows it.
Month six also looks different from month one on each. On Hone Health, once a dose settles, the product becomes a repeating prescription plus a quarterly test, and the question becomes whether the membership still earns its place around the medication. On Marek Health, month six is when the a la carte structure either justifies itself — because the protocol is still moving and each panel changes something — or starts charging for panels that keep reporting the same result. Cancellation is the other unplanned-for difference: on either platform, stopping mid-protocol means coming off a medication your body has adapted to, and a monthly membership is not a taper plan.
Frequently Asked Questions
Which is cheaper, Hone Health or Marek Health?
Hone Health, at every tier. Testing and membership start near $45/month, and an active TRT protocol with medication runs $150–$220+/month. Marek Health starts with a $200–$400 consult and builds from there to a $2,500–$6,000+ year one. The gap is scope: Marek Health is buying more labs, more prescription categories, and a faster retest cadence.
Which one prescribes peptides?
Marek Health has the broader prescription list — TRT, select peptides, and ancillaries such as aromatase inhibitors and HCG where clinically indicated. Hone Health is TRT-first with more limited peptide options. If a peptide protocol is part of the plan, that narrows the choice on its own.
Which is more turnkey?
Hone Health. One flow runs from the finger-prick kit through clinician review to shipped medication at a fixed monthly rate, and you are not asked to select panels. Marek Health assumes you can take part in choosing which labs to run, which is why it fits users who arrive with a specific protocol question.
How long until I get results and a prescription?
On Hone Health, results come back 5–7 days after the mailed sample arrives, and clinician review of candidacy follows that. Marek Health starts with a physician consult and a venous baseline panel at a partner lab, so the timeline depends on how quickly you can get to a draw site and how deep the ordered panel is.
What happens if I cancel mid-protocol?
Canceling either membership ends the prescription, not the physiology. Exogenous TRT suppresses your own LH and FSH signaling, so coming off it is a clinical taper question rather than a subscription question. Raise it with the prescribing clinician before you cancel, on either platform, and ask what the exit plan looks like.
Can I use an HSA or FSA?
Neither platform bills insurance for the membership. Whether a specific charge is HSA or FSA eligible depends on your plan administrator and on whether the item is a qualifying medical expense — lab work and prescribed medication are treated differently from a membership fee. Ask for itemized receipts rather than a single monthly charge, since a lump membership line is harder to substantiate.
Can I start on one and switch later?
Yes, and moving from Hone Health to Marek Health is the more common direction — a protocol that grows past testosterone outgrows a TRT-first platform. Take your lab history with you. A new physician will usually want a fresh baseline anyway, so budget one duplicate panel in the switch.
Do I need a doctor already to use either?
No. Both bundle their own prescribing clinician, so no outside referral is required. Neither replaces a primary care physician, though. Both work from a hormone-focused view, and neither carries your full medical history, so anything outside that scope still needs a regular doctor.